Acquisition | UROVANT SCIENCES LTD | 30th March 2021

Due to the acquisition of UROVANT SCIENCES LTD by SUMITOVANT BIOPHARMA LTD, the following treatment will be applied to the following indices:

• UROVANT SCIENCES LTD will be removed from the Index.
• The weight of UROVANT SCIENCES LTD based on its last close price will be distributed pro rata to remaining Index constituents.
• Effective Date (open): 03/30/2021.

Solactive US Extended Broad Market Index (GTR)